The Cambridge spinout is commercialising research into better techniques for extracting quality stem cells, having raised a reported $464,000 in seed funding.

SNHU has backed edtech developer Edmit through the Rethink Education fund, a vehicle also backed by Rethink Education.

Saarland-founded AkknaTek is developing an imaging aid for cataract surgery to improve the precision of intraocular lenses implanted during the procedure.

Pep-Therapy has now raised $2.9m to deliver peptide-based cancer drugs that further research from Université Pierre et Marie Curie, Institut Curie and Inserm.

Imec spinout LynxCare has collected funding from investors including government-owned PMV and VLaio.

The Pittsburgh spinout is building a precision diagnostic platform that uses genomics to underpin research into conditions such as chronic pancreatic disease.

Neophore was launched by University of Cambridge biopharmaceutical developer PhoreMost in May 2017 to home in on potential immunotherapies for cancer.